Rachel E. Davis
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Organic Chemistry top 10%
- Quinazolinone synthesis and applications
- Synthesis and biological activity
Papers in
-
- Heat shock proteins research 8
- ATP Synthase and ATPases Research 3
- Cancer therapeutics and mechanisms 2
-
- Toxin Mechanisms and Immunotoxins 2
- Co-authors
- Brian S. J. Blagg (9 shared papers)Ramaswamy Nilakantan (2 shared papers)Lee M. Greenberger (2 shared papers)Allan Wissner (2 shared papers)Ru Shen (2 shared papers)Nellie Mamuya (2 shared papers)Marvin F. Reich (2 shared papers)Carolyn Discafani (2 shared papers)
- Journals
- Nature Communications (2 papers)Journal of Medicinal Chemistry (2 papers)MedChemComm (2 papers)Nature Cancer (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomPhilippines
In The Last Decade
Rachel E. Davis
15 papers receiving 985 citations
Rachel E. Davis's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 380
- Organic Chemistry 276
- Molecular Biology 592
- Computational Theory and Mathematics 83
- Radiology, Nuclear Medicine and Imaging 91
Countries citing papers authored by Rachel E. Davis
This map shows the geographic impact of Rachel E. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Davis more than expected).
Fields of papers citing papers by Rachel E. Davis
This network shows the impact of papers produced by Rachel E. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Davis. The network helps show where Rachel E. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel E. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors Hit paper breakdown → | 2021 | 232 |
| 2 | 2001 | 230 | |
| 3 | 2002 | 214 | |
| 4 | 2019 | 88 | |
| 5 | 2021 | 66 | |
| 6 | 2021 | 62 | |
| 7 | 2017 | 29 | |
| 8 | 2018 | 17 | |
| 9 | 2021 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2017 | 7 | |
| 14 | 2018 | 5 | |
| 15 | 2004 | 5 | |
| 16 | 2021 | 0 |
About Rachel E. Davis
Rachel E. Davis is a scholar working on Molecular Biology, Immunology, Oncology, Computational Theory and Mathematics and Organic Chemistry, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Heat shock proteins research (8 papers), Computational Drug Discovery Methods (3 papers), ATP Synthase and ATPases Research (3 papers), Enzyme Structure and Function (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Cancer therapeutics and mechanisms (2 papers), Quinazolinone synthesis and applications (2 papers) and thermodynamics and calorimetric analyses (2 papers). The work is most often cited by research in Oncology (380 citations), Organic Chemistry (276 citations), Molecular Biology (592 citations), Computational Theory and Mathematics (83 citations) and Radiology, Nuclear Medicine and Imaging (91 citations). Rachel E. Davis has collaborated with scholars based in United States, United Kingdom and Philippines. Frequent co-authors include Brian S. J. Blagg, Ramaswamy Nilakantan, Lee M. Greenberger, Allan Wissner, Ru Shen, Nellie Mamuya, Marvin F. Reich, Carolyn Discafani, Bernard D. Johnson and Hwei‐Ru Tsou. Their work appears in journals such as Nature Communications, Journal of Medicinal Chemistry, MedChemComm, Nature Cancer and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.